Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

1. NAPLEX Prep > Chapter 3- Drug Interactions > Flashcards

Chapter 3- Drug Interactions Flashcards

1
Q

Pharmacodynamics

A

The effect or change that the drug has on the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Additive effect toxicity

A

Drugs that have similar end effects through different mechanisms/receptors can cause additive effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk with concurrent use of benzodiazepines and opioids

A

Due to the heightened fatality risk when opioids and benzodiazepines are taken together, the FDA placed a boxed warning to all drugs in both classes.
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Aspirin + warfarin interaction

A

Warfarin causes anticoagulation through inhibition of vitamin K dependent clotting factors. Aspirin blocks the effects of platelets. They both cause increased bleeding and this effect is greater when taken together.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antagonist

A

Blocks the agonist from binding to its receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Naloxone as an antagonist

A

Naloxone is a mu-receptor antagonist; it saturates the mu receptors and blocks the opioid from binding. Naloxone is used to reverse respiratory depression, but will also reverse the analgesic effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Synergism

A

Present when two drugs taken in combination have a greater effect than obtained by simply adding the two individual drugs together.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Oxcodone + Acetaminophen synergy

A

The mechanisms of analgesia between oxycodone and acetaminophen are different and do not overlap. When taking the drugs together the effect is greater than the individual drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacokinetics

A

The effect the body has on the drug (ADME)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chelation

A

Occurs when a drug binds to polyvalent cations (ex, Mg++, Ca++, Fe++) in another compound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Example of chelation

A

antacids or iron supplements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chelation of quinolone antibiotics

A

Occurs when quinolones bind to calcium-containing drugs and dairy products. When taken together, the antibiotic will not dissolve, will not be absorbed, and the infection may not be adequately treated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples of drugs with polyvalent cations or other binding properties

A

Antacids, multivitamins, sucralfate, bile acid resins, aluminum, calcium, iron, magnesium, zinc, phosphate binders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Polyvalent cations should be separated from what drugs?

A

Quinolones, tetracyclines, levothyroxine. oral bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The majority of PK drug reactions occur during

A

metabolism in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ritonavir and darunavir interaction

A

Ritonavir inhibits the metabolism of darunavir, which “boosts” darunavir levels and increases its efficacy in treating HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clarithromycin + warfarin interaction

A

Clarithromycin inhibits warfarin metabolism, increasing the INR and risk of bleeding.
Warfarin would need to be decreased.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Rifampin + warfarin interactions

A

Rifampin induces warfarin metabolism, decreasing the INR and increasing the risk for blood clots.
Warfarin would need to be increased.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Primary route of drug excretion

A

Renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Probenacid + penicillin interaction

A

Probenacid blocks the renal excretion of penicillin. Giving probenacid with penicillin can be beneficial when high penicillin levels are needed to cross the BBB and provide effective treatment of neurosyphilis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Sodium bicarbonate + aspirin interaction

A

Salicylate overdose results in toxicity.
IV sodium bicarb alkalinizes the urine, causing salicylate to become ionized. Ionized compounds are more hydrophilic and will stay in the urine, causing less to be reabsorbed in the renal tubules. Compounds that stay in the urine will be renally excreted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the purpose of CYP450 enzymes?

A

catalyze Phase I reactions that either produce essential compounds or uncover or insert a polar group on a compound to facilitate renal excretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prodrugs

A

Taken in an inactive form and are converted by CYP450 into the active form.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Why are prodrugs used?

A

To extend the dosing interval and to prevent drug abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Prodrug and active metabolite Capecitabine
Fluorouracil
26
Prodrug and active metabolite Clopidogrel
Active metabolite
27
Prodrug and active metabolite Codeine
Morphine
28
Prodrug and active metabolite Colistimethate
Colistin
29
Prodrug and active metabolite Cortisone
Cortisol
30
Prodrug and active metabolite Famciclovir
Penciclovir
31
Prodrug and active metabolite Fosphenytoin
Phenytoin
32
Prodrug and active metabolite Isavuconazonium sulfate
Isavuconazole
33
Prodrug and active metabolite Levodopa
Dopamine
34
Prodrug and active metabolite Lisdexamfetamine
Dextroamphetamine
35
Prodrug and active metabolite Prednisone
Prednisolone
36
Prodrug and active metabolite Primidone
Phenobarbital
37
Prodrug and active metabolite Tramadol
Active metabolite
38
Prodrug and active metabolite Valacyclovir
Acyclovir
39
Prodrug and active metabolite Valganciclovir
Ganciclovir
40
Do not use codeine in
UMs of 2D6
41
Do not use clopidogrel with
PMs of CYP2C19 or CYP2C19 inhibitors
42
NATs are highly
Polymorphic
43
CYP enzyme inhibitors
Decrease enzyme function and the ability to metabolize compounds.
44
CYP enzyme substrates
Drugs that are substrates for the same CYP enzyme will have a decreased rate of drug metabolism and an increased serum drug level. In some cases, less drug will be lose to first pass metabolism.
45
Enzyme inhibition
Very fast. Effects are seen within a few days and will end quickly when the inhibitor is discontinued.
46
Common CYP inhibitors
G PACMAN Grapefruit Protease inhibitors (especially ritonavir) Azole antifungals Cyclosporine, cobicistat Macrolides (Clarithromycin and erythromycin, NOT azithromycin) Amiodarone and dronedarone Non-DHP CCBs (diltiazem and verapamil)
47
CYP inhibition effect on substrates
Decreased metabolism Increased serum levels and clinical effects INhibitors=INcreased effects/levels/ADRs/toxicities
48
CYP inhibition effect on prodrugs
Decreased conversion to the active drug (decreased serum levels and clinical effects)
49
Possible actions for CYP inhibition of a substrate
Decrease dose of substrate (unless a prodrug), use alternate drug to avoid combination.
50
CYP enzyme inducers ________ the concentration of substrate drugs
Decrease
51
Drug enzyme inducers _________ enzyme production or activity
Increase
52
Common CYP inducers involved in drug interactions
PS PORCS Phenytoin Smoking Phenobarbital Oxcarbazepine Rifampin, rifabutin, rifapentine Carbamazepine (also an auto inducer) St. Johns Wort
53
CYP inducers effect on substrates
Increased metabolism Decreased serum levels and clinical effects InDucers=Decreased effects/levels
54
CYP inducer effects on prodrugs
Increased conversion to the active drugs (increase serum levels and clinical effects)
55
CYP inducers solution
Increase the dose of the substrate (unless a prodrug), use alternative drug to avoid combination.
56
Timing for enzyme induction
Lag time. Induction most often requires additional enzyme production, which takes time. The full effect on drug levels may not be seen for up to 4 weeks. When the inducer is stopped in could take 2-4 weeks for the induction effects to disappear completely; the excess enzyme will degrade based on their half lives.
57
What do P-gp efflux pumps do?
Protect against foreign substances by moving them out of critical areas
58
Where do P-gp pumps transport drugs?
P-gp pumps in the cell membranes of the GI tract transport drugs and their metabolites out of the body by pumping then into the gut where they can be excreted in the stool.
59
When a drug blocks or inhibits P-gp, a drug that is a P-gp substrate will
have increased absorption (less drug is pumped into the gut) and the substrate drug level will increase
60
Common P-gp substrates
Anticoagulants- apixaban, edoxaban, dabigatran, rivaroxaban Cardiovascular drugs- digoxin, diltiazem, carvedilol, ranolazine, verapamil Immunosuppressants- cyclosporine, sirolimus, tacrolimus HCV drugs- dasabuvir, ombitasvir, paritaprevir, sofosbuvir Others- atazanavir, colchicine, dolutegravir, posaconazole, raltegravir, saxagliptin
61
Common P-gp inducers
Carbamazepine, dexamethasone, phenobarbital, phenytoin, rifampin, St. Johns wort, tipranavir
62
Common P-gp inhibitors
Antiinfectives- clarithromycin, itraconazole, posaconazole Cardiovascular drugs- amiodarone, carvedilol, conivaptan, diltiazem, dronedarone, quinidine, verapamil HIV drugs- cobicistat, ritonavir HCV drugs- ledipasvir, paritaprevir Others- cyclosporine, flibanserin, ticagrelor
63
Enterohepatic recycling
After a drug has been metabolized in the liver, it can be transported through the bile back to the gut. From the gut, the drug can be reabsorbed (primarily in the small intestine), enter into the portal vein and travel back to the liver. The recycling of an already metabolized drug is called enterohepatic recycling, which increases the duration of action of many drugs, including some abx, NSAIDs, and ezetimibe.
64
Amiodarone + Warfarin drug interaction
Amiodarone inhibits multiple enzymes, including CYP2C9, which metabolizes the more potent warfarin isomer. Decreased warfarin metabolism causes increased INR and bleeding risk.
65
Amiodarone + Warfarin drug interaction actions by pharmacists
If using amiodarone 1st and adding warfarin- start warfarin at a lower dose
66
When can amiodarone and warfarin be used together?
Can be used together for Afib. Amiodarone for rhythm control and warfarin to reduce clot risk
67
Amiodarone + Digoxin drug interaction
Amiodarone inhibits P-gp; digoxin is a P-gp substrate. Decreases digoxin excretion and increases ADRs/toxicity Amiodarone and digoxin both decrease heart rate, increase risk of bradycardia, arrhythmia, fatality
68
Amiodarone + Digoxin actions by pharmacists
If using amiodarone 1st: -Start oral digoxin at low dose, such as 0.125 mg daily If using digoxin 1st: -Decrease digoxin dose by 50% Taking both: -Monitor for signs of digoxin toxicity; nausea, vomiting, vision changes -Monitor HR, check for other drugs that decrease HR -If digoxin is being used for rate control, recommend beta blockers or non-DHP CCBs instead
69
Drugs that decrease HR
Digoxin, amiodarone, beta blockers, clonidine, diltiazem, verapamil, Precedex
70
When would amiodarone and digoxin be used together?
Can be given together for Afib treatment. Amiodarone- rhythm control Digoxin- rate control or for symptom management in heart failure
71
Digoxin + Loop diuretic interaction
Loop diuretics decrease K, Mg, Ca, and Na. Low K, Mg, or Ca worsen arrhythmias. Digoxin toxicity risk increases with decreased K and Mg levels and increased Ca levels. Another caution- HF and renal impairment commonly occur together. Digoxin is cleared by P-gp and excreted by the kidneys. Renal impairment (exacerbated by loop diuretics) increases digoxin levels and toxicity risk.
72
Digoxin + loop diuretic pharmacists action
Monitor electrolytes and correct if abnormal. Renal impairment: Decrease digoxin dose or frequency, or discontinue
73
When would digoxin and loop diuretics be used together?
For heart failure treatment Digoxin is for symptom improvement and loop diuretics alleviate fluid overload.
74
Statins + Strong 3A4 inhibitor interaction
Increase levels of 3A4 substrates: lovastatin, simvastatin, and atorvastatin Increased myopathy risk; if severe (with high CPK), can cause rhabdomyolysis with acute renal failure
75
Statins + Strong 3A4 inhibitor pharmacist action
Simvastatin and lovastatin are contraindicated with strong 3A4 inhibitors. Recommend a statin not metabolized by CYP450 enzymes. Pitavastatin, pravastatin, rosuvastatin
76
Warfarin + CYP2C9 inhibitors and inducers
Increased levels of warfarin (increased INR and bleeding risk) with CYP2C9 inducers Decreased levels of warfarin (decreased INR and increased clotting risk) with CYP2C9 inducers
77
CYP2C9 inhibitors
Azole antifungals, sulfamethoxazole/trimethoprim, amiodarone, metronidazole
78
CYP2C9 inducers
Rifampin, St.Johns wort
79
Warfarin + CYP2C9 inhibitors or inducer pharmacist action
Monitor INR Some drugs (amiodarone) requires prophylactic warfarin dose adjustment before started
80
CYP3A4 substrates +CYP3A4 inhibitors DDI
Decreased 3A4 substrate (drug) metabolism will cause increased levels and toxicity.
81
Do not use a CYP3A4 inhibitor with an opioid metabolized by
CYP3A4
82
Do not take grapefruit with
CYP3A4 substrates Including simvastatin, lovastatin, amiodarone, nifedipine, tacrolimus
83
Valproate + Lamotrigine DDI
Valproate is an inhibitor of Lamotrigine metabolism. This increases lamotrigine levels and increases risk of serious skin infections SJS/TEN
84
Valproate + Lamotrigine DDI Pharmacist action
Initiate lamotrigine using the starter kit that begins with lower lamotrigine doses. Titrate carefully every 2 weeks and counsel on rash
85
Monoamine oxidase inhibitors
Isocarboxazid, phenelzine, tranylcypromine, rasagiline, selegiline, linezolid, methylene blue
86
Drugs that increase Epi/NE/DA
SNRIs, TCAs, bupropion, levodopa, stimulants, tyramine
87
Drugs that increase serotonin
Antidepressants, fentanyl, methadone, tramadol, buspirone, dextromethorphan (when abused), lithium, St. Johns wort
88
MAO inhibitors with drugs/food that increase Epi/NE/DA or 5-HT3
MAO enzyme metabolizes Epi, NE, DA, tyramine, and 5-HT. Blocking MAO with an MAO inhibitor will increase Epi, NE, DA, and 5-HT High EPI/NE/DA can cause hypertensive crisis High 5-HT3 can cause serotonin syndrome Do not use together. have a 2 week washout period
89
Tyramine rich foods
Aged cheeses, air-dried meats, sauerkraut, some wines/beers Foods that have been aged, pickled, fermented, or smoked
90
CYP2D6 inhibitors
Amiodarone, fluoxetine, paroxetine, fluvoxamine
91
CYP2D6 substrates
Many, including codeine, meperidine, tramadol, tamoxifen
92
CYP2D substrates + inhibitors DDI
Decrease substrate metabolism increases ADR/toxicity (or decreased clinical efficacy if prodrug) Avoid using together if possible
93
CYP3A4, P-G inhibitors + calcineurin inhibitors or mTOR kinase inhibitors DDI
Decrease drug substrate metabolism, increases ADRs/toxicity' Avoid
94
Antiepileptic drugs CYP inducers
Phenytoin, phenobarbital, primidone, carbamazepine, oxcarbazepine
95
Antiepileptic drugs CYP inducers + other drugs metabolized by CYP enzymes
Increases substrate metabolism and decreases drug levels and seizure control. Monitor drug levels and consider increasing the dose. If substrate is lamotrigine, use starter kit
96
Rifampin + CYP and Pgp substrates
The concentration of the substrate drugs will greatly decrease. Monitor
97
CYP2D6 UM + prodrugs that are 2D6 substrates (codeine, tramadol)
with 2D6 UMs, the prodrug will be converted more rapidly into its active drug, increasing active drug concentrations and causing toxicity
98
Are there any CYP2D6 inducers?
No
99
Do not use codeine or tramadol in
children <12 yo or <18 yo following tonsillectomy and/or adenoidectomy Breastfeeding mothers unless it is known that she is not a 2D6 UM
100
CYP3A4, Pgp inducers + CNIs or mTOR kinase inhibitors
Increase drug metabolism results in decreased transplant drug level and increase risk of transplant rejection
101
Smoking (tobacco, marijuana) DDI
Smoking induces 1A2 When the inducer (cigarettes) is stopped, drug concentrations of CYP1A2 substrates will increase, causing toxicity. In current smokers, 1A2 substrates will have decreased levels
102
Hyperkalemia symptoms
Weakness, heart palpitations, arrhythmias Higher risk with renal impairment
103
What drugs have risk of hyperkalemia?
RAAS drugs- ACEi, ARBs, aliskiren, sacubitril/valsartan, spironolactone, eplerenone Potassium sparing diuretics- amiloride, triamterene Others- salt substitutes (KCl), calcineurin inhibitors (cyclosporine, tacrolimus), SMX/TMP, canagliflozin, drosperinone-containing oral contraceptives
104
Do not use sacubitril/valsartan with
ACEis or ARBs
105
Drugs with increase bleeding risk
Anticoagulants Antiplatelets NSAIDs SNRIs/SSRIs Natural products- 5Gs: Ginger, garlic, ginkgo biloba, ginseng, glucosamine Vitamin E, willow bark, fish oils (high doses)
106
Drugs with risk of serotonergic toxicity
Antidepressants MAOinhibitors Opioids Triptans Natural products- St.Johns wort, L-tryptophan Others- buspirone, lithium, dextromethorphan (in abuse)
107
Serotonin syndrome symptoms
Range from mild to severe and fatal Autonomic dysfunction (diaphoresis, nausea, vomiting, hyperthermia) Altered mental status (akathisia, anxiety, agitation, delirium) Neuromuscular excitation: Hyperreflexia, tremor, rigidity, tonic-clonic seizure
108
Drugs that cause QTc prolongation
Antiarrhythmics, SSRIs, escitalopram, TCAs, trazodone, mirtazapine, venlafaxine, antimalarials, azole antifungals, lefamulin, macrolides, quinolones, 1st gen antipsychotics, 2nd gen antipsychotics, ondansetron, droperidol, metoclorpamide, promethazine, androgen deprivation therapy, methadone, tacrolimus
109
Do not exceed citalopram
40 mg QD or 20 mg QD in elderly (>60), liver disease, or with enzyme inhibitors
110
Do not use droperidol for
inpatient N/V
111
Which SSRI is safest for CVD?
Sertraline
112
Drugs with ototoxicity
Aminoglycosides- gentamicin, tobramycin, amikacin Cisplatin Loop diuretics (especially in rapid IV) Salicylates Vancomycin
113
Drugs with nephrotoxicity
Anti-infectives- aminoglycosides, amphotericin B, polymyxins, vancomycin Cisplatin Calcineurin inhibitors- tacrolimus, cyclosporine Loop diuretics- furosemide, torsemide, bumetanide, ethacrynic acid NSAIDs Radiographic-contrast dye
114
What do you use with cisplatin to reduce nephrotoxicity?
Amifostine

1. NAPLEX Prep (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions